Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) 3-Year EBITDA Growth Rate : 22.10% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Beijing Wantai Biological Pharmacy Enterprise Co 3-Year EBITDA Growth Rate?

Beijing Wantai Biological Pharmacy Enterprise Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.10.

During the past 12 months, Beijing Wantai Biological Pharmacy Enterprise Co's average EBITDA Per Share Growth Rate was -98.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 22.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 58.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 42.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Beijing Wantai Biological Pharmacy Enterprise Co was 156.90% per year. The lowest was 4.60% per year. And the median was 33.70% per year.

Competitive Comparison of Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year EBITDA Growth Rate falls into.

Beijing Wantai Biological Pharmacy Enterprise Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Beijing Wantai Biological Pharmacy Enterprise Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 31, Science Park Road, Beiqing Road, Changping District, Beijing, CHN, 102206

Website

http://www.ystwt.com

Beijing Wantai Biological Pharmacy Enterprise Co Ltd is an engaged in the research and development and production of biodiagnostic reagents and vaccines. The company produces chemiluminescence, nucleic acid, clinical biochemistry and other testing reagents and clinical inspection quality control products and vaccines. Its products include ELISA series, Colloidal gold series, Bole series, Confirmation series, Automatic blood group analyzer and reagent, Chemiluminescence series, Nucleic acid series, and Research Series.

Executives

Zhao Yi Yong	senior management
Li Yi Min	senior management
Zhao Ling Zhi	Directors, senior managers
Qiu Zi Xin	Directors, senior managers
Li Sha Yan	senior management
Ye Xiang Zhong	Directors, senior managers
Gao Yong Zhong	Director

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Headlines

No Headlines